Table 2 Characteristics of vitreomacular interface clusters in central retinal vein occlusion (CRVO).
Cluster 0 (non-VMA) | Cluster 1 (VMA) | p | |||
|---|---|---|---|---|---|
N= | 82 | 116 | |||
Baseline BCVA (mean +− SD) | 58.35 +− 12.61 | 50.85 +− 15.52 | 0.0004 | ||
BCVA change at month 12 (mean +− SD) | 9.40 +− 12.99 | 17.65 +− 13.61 | 0.0004 | ||
Baseline CRT (mean +− SD) | 630.50 +− 78.50 | 707.36 +− 300.53 | 0.7471 | ||
CRT change at month 12 (mean +− SD) | −423.50 +− 125.50 | −468.40 +− 353.92 | 0.8747 | ||
Baseline ILM-VIT distance (mean +− SD) | 2.38 +− 2.47 | 13.71 +− 12.41 | <0.0001 | ||
Number of ranibizumab injections (mean +− SD) | 8.08 +− 2.74 | 8.32 +− 2.68 | 0.6470 | ||
Cluster 0 (non-VMA) | Cluster 1 (VMA) | Cluster 2 (VMA) | p | ||
N= | 44 | 68 | 86 | ||
Baseline BCVA (mean +− SD) | 61.00 +− 11.57 | 54.90 +− 14.23 | 49.64 +− 15.32 | 0.0001 | |
BCVA change at month 12 (mean +− SD) | 8.41 +− 13.87 | 13.00 +− 13.65 | 17.85 +− 13.08 | 0.0059 | |
Baseline CRT (mean +− SD) | 630.50 +− 78.50 | 485.00 +− 0.00 | 729.60 +− 306.45 | 0.7208 | |
CRT change at month 12 (mean +− SD) | −423.50 +− 125.50 | −212.00 +− 0.00 | −496.89 +− 362.02 | 0.7593 | |
Baseline ILM-VIT distance (mean +− SD) | 1.12 +− 0.75 | 4.57 +− 3.50 | 16.58 +− 13.05 | <0.0001 | |
Number of ranibizumab injections (mean +− SD) | 8.00 +− 2.95 | 7.78 +− 2.55 | 8.64 +− 2.61 | 0.3026 | |
Cluster 0 (non-VMA) | Cluster 1 (VMA) | Cluster 2 (VMA) | Cluster 3 (VMA) | p | |
N= | 40 | 57 | 48 | 53 | |
Baseline BCVA (mean +− SD) | 61.56 +− 11.52 | 55.54 +− 13.26 | 49.67 +− 15.74 | 50.45 +− 15.35 | 0.0004 |
BCVA change at month 12 (mean +− SD) | 8.97 +− 13.61 | 11.37 +− 12.89 | 20.13 +− 17.32 | 16.27 +− 9.71 | 0.0058 |
Baseline CRT (mean +− SD) | 630.50 +− 78.50 | 485.00 +− 0.00 | 709.50 +− 367.10 | 743.00 +− 257.35 | 0.8855 |
CRT change at month 12 (mean +− SD) | −423.50 +− 125.50 | −212.00 +− 0.00 | −612.00 +− 441.35 | −439.33 +− 298.76 | 0.8143 |
Baseline ILM-VIT distance (mean +− SD) | 1.07 +− 0.73 | 4.35 +− 3.74 | 6.24 +− 3.73 | 22.56 +− 13.15 | <0.0001 |
Number of ranibizumab injections (mean +− SD) | 7.89 +− 2.95 | 7.77 +− 2.68 | 8.21 +− 2.94 | 8.94 +− 2.09 | 0.3290 |